Education
About Us
Working with TipRanks
Follow Us
Turn Therapeutics Inc (TTRX)
NASDAQ:TTRX
Total Valuation
Turn Therapeutics Inc has a market cap or net worth of $110.42M. The enterprise value is -$751.56K.
Market Cap$110.42M
Enterprise Value-$751.56K
Share Statistics
Turn Therapeutics Inc has 29,445,183 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding29,445,183
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Turn Therapeutics Inc’s return on equity (ROE) is 9.97 and return on invested capital (ROIC) is -130.07%.
Return on Equity (ROE)9.97
Return on Assets (ROA)-0.86
Return on Invested Capital (ROIC)-130.07%
Return on Capital Employed (ROCE)-1.34
Revenue Per Employee0.00
Profits Per Employee-884.21K
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Turn Therapeutics Inc is ―. Turn Therapeutics Inc’s PEG ratio is 0.00.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value0.00
Price to FCF0.00
Price to Operating Cash Flow―
PEG Ratio0.00
Income Statement
In the last 12 months, Turn Therapeutics Inc had revenue of 0.00 and earned -1.77M in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit0.00
Operating Income-1.80M
Pretax Income-1.77M
Net Income-1.77M
EBITDA-1.75M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Turn Therapeutics Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-1.03
52-Week Price Change-59.78%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)2.86M
Important Dates
Turn Therapeutics Inc upcoming earnings date is Nov 13, 2025, Before Open (Confirmed).
Last Earnings DateInvalid Date
Next Earnings DateNov 13, 2025
Ex-Dividend Date―
Financial Position
Turn Therapeutics Inc as a current ratio of 1.55, with Debt / Equity ratio of ―
Current Ratio1.55
Quick Ratio1.55
Debt to Market Cap0.00
Net Debt to EBITDA0.43
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Turn Therapeutics Inc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Turn Therapeutics Inc EV to EBITDA ratio is 0.43, with an EV/FCF ratio of 0.51.
EV to Sales0.00
EV to EBITDA0.43
EV to Free Cash Flow0.51
EV to Operating Cash Flow0.55
Balance Sheet
Turn Therapeutics Inc has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total Debt―
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share$0.00
Margins
Gross margin is ―, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin―
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Turn Therapeutics Inc is $6.77, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$6.77
Price Target Upside146.96% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast―